Heligenics

Heligenics develops a technology showing the genetic mutation impact to transform genetic testing and drug development for major diseases.

Heligenics is active in the biotechnology, health care, health diagnostics, life science, wellness space based in Western US, founded in 2017.

Its activity falls under biotechnology, health care, health diagnostics, life science, wellness; the profile below is assembled from public directory data.

Western US is where the company is located.

The company is listed at the Series_Unknown stage of development.

The company reports a headcount in the c_00011_00050 range.

It has disclosed roughly $3.3M in funding.

Website: heligenics.com